YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSGY8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,670
Award facts
- Contract value 100% obligated
- $1,670.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program (contract SPE2DR), valued at $499,999,999 with a completion date of December 31, 2036, which authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies including branded and generic prescription drugs, biologics, vaccines, and medical consumables. The company has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with awards ranging from under $100 to over $115,000, positioning DMS Pharmaceutical Group as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSGY8?
SPE2DR26FSGY8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FSGY8 worth?
The government has obligated $1,670 on SPE2DR26FSGY8.
Is contract SPE2DR26FSGY8 an order under another contract?
Yes. SPE2DR26FSGY8 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSGY8 competed?
The extent of competition for SPE2DR26FSGY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award